Recombinant Human FGF-9 Protein

Recombinant human FGF-9 (273-F9) induces proliferation in the Balb/3T3 mouse embryonic fibroblast cell line. The ED50 for this effect is 1-5 ng/mL.

• Reactivity: Hu
• Applications: Bioactivity

Recombinant Human FGF-9 Protein Summary

• Additional Information: Sf21-Expressed
• Details of Functionality: Measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblast cells. Rubin, J.S. et al. (1991) Proc. Natl. Acad. Sci. USA 88:415. The ED 50 for this effect is 1-5 ng/mL.
• Source: Spodoptera frugiperda, Sf 21 (baculovirus)-derived human FGF-9 protein Met1-Ser208 & Ala2-Ser208
• Accession #: P31371
• N-terminal Sequence: Met1 & Ala2
• Protein/Peptide Type: Recombinant Proteins
• Gene: FGF9
• Purity: >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
• Endotoxin Note: <1.0 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

• Dilutions:
  • Bioactivity
• Theoretical MW: 23 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
• SDS-PAGE: Multiple bands between 22-29 kDa, reducing conditions

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  12 months from date of receipt, -20 to -70 degreesC as supplied. 3 months, 2 to 8 degreesC under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 and EDTA with BSA as a carrier protein.
• Purity: >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
• Reconstitution Instructions: Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human FGF-9 Protein

• FGF9
• FGF-9
• fibroblast growth factor 9 (glia-activating factor)
• Fibroblast growth factor 9
• GAF
• glia-activating factor
• HBFG-9
• HBGF-9
• Heparin-binding growth factor 9
• MGC119914
• MGC119915
• SYNS3

Background

FGF-9 (fibroblast growth factor-9), also called HBGF-9 (heparin-binding growth factor-9) and GAF (glia-activating factor), is an approximately 26 kDa secreted glycoprotein of the FGF family (1-3). FGFs exhibit heparin-dependent regulation of cell proliferation, differentiation, and function, and are characterized by a core heparin-binding FGF domain of approximately 120 amino acids (aa) that exhibits a beta -trefoil structure (1). FGF-9, -16 and -20 form a subfamily that shares 65-71% aa sequence identity, binds FGF R3 (IIIb), and are efficiently secreted despite having an uncleavable, bipartite signal sequence (1-3). Secreted human FGF-9 is a 205-207 aa protein that lacks the N-terminal 1-3 aa and shares 98% sequence identity with mouse, rat, equine, porcine and bovine FGF-9. In addition to FGF R3 (IIIb), FGF-9 binding to the IIIc splice forms of FGF R1, R2 and R3 are variably reported (3-5). An unusual constitutive dimerization of FGF-9 buries receptor interaction sites which lowers its activity, and increases heparin affinity which inhibits diffusion (4-6). A spontaneous mouse mutant, Eks, interferes with dimerization, resulting monomeric, diffusible FGF-9 that causes elbow and knee synostoses (joint fusions) due to FGF-9 misexpression in developing joints (6). In humans, FGF-9 mutations that lower receptor binding cause multiple synostoses syndrome (SYNS) (7). Expression in brain and kidney are reported in the adult rat (2, 8). In the mouse embryo the location and timing of FGF-9 expression affects development of the skeleton, cerebellum, lungs, heart, vasculature, digestive tract, and testes (1, 6-11). Deletion of mouse FGF-9 is lethal at birth due to lung hypoplasia, and causes rhizomelia, or shortening of the proximal skeleton (1, 10, 11). Altered FGF-9 expression or function is reported in human colon, endometrial, and ovarian cancers, correlating with progression, invasiveness, and survival (12-15).

1. Itoh, N. and D.M. Ornitz (2008) Dev. Dyn. 237:18.
2. Miyamoto, M. et al. (1993) Mol. Cell. Biol. 13:4251.
3. Santos-Ocampo, S. et al. (1996) J. Biol. Chem. 271:1726.
4. Mohammadi, M. et al. (2005) Cytokine Growth Factor Rev. 16:107.
5. Plotnikov, A.N. et al. (2001) J. Biol. Chem. 276:4322.
6. Harada, M. et al. (2009) Nat. Genet. 41:289.
7. Wu, X.L. et al. (2009) Am. J. Hum. Genet. 85:53.
8. Colvin, J.S. et al. (1999) Dev. Dyn. 216:72.
9. Lin, Y. et al. (2009) Dev. Biol. 329:44.
10. Hung, I.H. et al. (2007) Dev. Biol. 307:300.
11. Colvin, J.S. et al. (2001) Dev. Dyn 128:2095.
12. Krejci, P. et al. (2009) Hum. Mutat. 30:1245.
13. Leushacke, M. et al. (2011) PLoS ONE 6:e23381.
14. Hendrix, N.D. et al. (2006) Cancer Res. 66:1354.
15. Abdel-Rahman, W.M. et al. (2008) Hum. Mutat. 29:390.

Publications for FGF-9 (273-F9)(47)

Publications using 273-F9

• Schnell, J;Miao, Z;Achieng, M;Fausto, CC;Wang, V;Kuyper, F;Thornton, ME;Grubbs, B;Kim, J;Lindström, NO; Stepwise developmental mimicry generates proximal-biased kidney organoids bioRxiv : the preprint server for biology 2024-07-02 [PMID: 39005387] (Bioassay, Human)
• Namoto, K;Baader, C;Orsini, V;Landshammer, A;Breuer, E;Dinh, KT;Ungricht, R;Pikiolek, M;Laurent, S;Lu, B;Aebi, A;Schönberger, K;Vangrevelinghe, E;Evrova, O;Sun, T;Annunziato, S;Lachal, J;Redmond, E;Wang, L;Wetzel, K;Capodieci, P;Turner, J;Schutzius, G;Unterreiner, V;Trunzer, M;Buschmann, N;Behnke, D;Machauer, R;Scheufler, C;Parker, CN;Ferro, M;Grevot, A;Beyerbach, A;Lu, WY;Forbes, SJ;Wagner, J;Bouwmeester, T;Liu, J;Sohal, B;Sahambi, S;Greenbaum, LE;Lohmann, F;Hoppe, P;Cong, F;Sailer, AW;Ruffner, H;Glatthar, R;Humar, B;Clavien, PA;Dill, MT;George, E;Maibaum, J;Liberali, P;Tchorz, JS; NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo Cell stem cell 2024-04-04 [PMID: 38579685] (Bioassay, Human)
• Karl, K;Del Piccolo, N;Light, T;Roy, T;Deduja, P;Ursachi, VC;Fafilek, B;Krejci, P;Hristova, K; Ligand bias underlies differential signaling of multiple FGFs via FGFR1 eLife 2024-04-03 [PMID: 38568193] (Bioassay, Human)
• Porter, CM;Qian, GC;Grindel, SH;Hughes, AJ; Highly-parallel production of designer organoids by mosaic patterning of progenitors bioRxiv : the preprint server for biology 2023-10-25 [PMID: 37961546] (Bioassay, Human)
• Shi, M;Fu, P;Bonventre, JV;McCracken, KW; Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells Nature protocols 2023-07-17 [PMID: 37460630] (Bioassay, Human)
• Yoshimura, Y;Muto, Y;Ledru, N;Wu, H;Omachi, K;Miner, JH;Humphreys, BD; A single-cell multiomic analysis of kidney organoid differentiation Proceedings of the National Academy of Sciences of the United States of America 2023-05-16 [PMID: 37155865] (Bioassay, Human)
• J Jansen, KC Reimer, JS Nagai, FS Varghese, GJ Overheul, M de Beer, R Roverts, D Daviran, LAS Fermin, B Willemsen, M Beukenboom, S Djudjaj, S von Stillf, LE van Eijk, M Mastik, M Bulthuis, WD Dunnen, H van Goor, JL Hillebrand, SH Triana, T Alexandrov, MC Timm, BT van den Be, M van den Br, Q Nlandu, J Heijnert, EMJ Bindels, RM Hoogenboez, F Mooren, C Kuppe, P Miesen, K Grünberg, T Ijzermans, EJ Steenberge, J Czogalla, MF Schreuder, N Sommerdijk, A Akiva, P Boor, VG Puelles, J Floege, TB Huber, COVID Moon, RP van Rij, IG Costa, RK Schneider, B Smeets, R Kramann SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids Cell Stem Cell, 2021-12-25;29(2):217-231.e8. 2021-12-25 [PMID: 35032430] (Bioassay, Human)
• R Ungricht, L Guibbal, MC Lasbennes, V Orsini, M Beibel, A Waldt, R Cuttat, W Carbone, A Basler, G Roma, F Nigsch, JS Tchorz, D Hoepfner, PS Hoppe Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis Cell Stem Cell, 2021-11-29;0(0):. 2021-11-29 [PMID: 34847364] (Bioassay, Human)
• JOR Hernandez, X Wang, M Vazquez-Se, M Lopez-Marf, MF Sobral-Rey, A Moran-Horo, M Sundberg, DO Lopez-Cant, CK Probst, GU Ruiz-Espar, K Giannikou, R Abdi, EP Henske, DJ Kwiatkowsk, M Sahin, DR Lemos A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo Nature Communications, 2021-11-11;12(1):6496. 2021-11-11 [PMID: 34764250] (Bioassay, Human)
• K Sasaki, A Oguchi, K Cheng, Y Murakawa, I Okamoto, H Ohta, Y Yabuta, C Iwatani, H Tsuchiya, T Yamamoto, Y Seita, M Saitou The embryonic ontogeny of the gonadal somatic cells in mice and monkeys Cell Reports, 2021-05-04;35(5):109075. 2021-05-04 [PMID: 33951437] (Bioassay, Human)
• Y Yamamura, K Furuichi, Y Murakawa, S Hirabayash, M Yoshihara, K Sako, S Kitajima, T Toyama, Y Iwata, N Sakai, K Hosomichi, PM Murphy, A Tajima, K Okita, K Osafune, S Kaneko, T Wada Identification of candidate PAX2-regulated genes implicated in human kidney development Scientific Reports, 2021-04-27;11(1):9123. 2021-04-27 [PMID: 33907292] (Bioassay, Human)
• M Chiara Per, N Bellitto, ERS Maylem, F Caloni, LJ Spicer Effects of selected hormones and their combination on progesterone and estradiol production and proliferation of feline granulosa cells cultured in�vitro Theriogenology, 2021-03-28;168(0):1-12. 2021-03-28 [PMID: 33826978] (Bioassay, Feline)
• SE Howden, SB Wilson, E Groenewege, L Starks, TA Forbes, KS Tan, JM Vanslambro, EM Holloway, YH Chen, S Jain, JR Spence, MH Little Plasticity of distal nephron epithelia from human kidney organoids enables the induction of ureteric tip and stalk Cell Stem Cell, 2020-12-29;0(0):. 2020-12-29 [PMID: 33378647] (Bioassay, Human)
• K Uchimura, H Wu, Y Yoshimura, BD Humphreys Human Pluripotent Stem Cell-Derived Kidney Organoids with Improved Collecting Duct Maturation and Injury Modeling Cell Reports, 2020-12-15;33(11):108514. 2020-12-15 [PMID: 33326782] (Bioassay, Human)
• IM Knarston, S Pachernegg, G Robevska, I Ghobrial, PX Er, E Georges, M Takasato, AN Combes, A Jørgensen, MH Little, AH Sinclair, KL Ayers An In�Vitro Differentiation Protocol for Human Embryonic Bipotential Gonad and Testis Cell Development Stem Cell Reports, 2020-11-19;15(6):1377-1391. 2020-11-19 [PMID: 33217324] (Cell Culture, Human)
• S Ettou, YL Jung, T Miyoshi, D Jain, K Hiratsuka, V Schumacher, ME Taglienti, R Morizane, PJ Park, JA Kreidberg Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury Sci Adv, 2020-07-24;6(30):eabb5460. 2020-07-24 [PMID: 32754639] (Bioassay, Human)
• Kumar Gupta A, Sarkar P, Wertheim J, Pan X, Carroll T, Oxburgh L Asynchronous mixing of kidney progenitor cells potentiates nephrogenesis in organoids. Commun Biol, 2020-05-11;3(1):231. 2020-05-11 [PMID: 32393756] (Bioassay, Human)
• M Grosch, S Ittermann, E Rusha, T Greisle, C Ori, DJ Truong, AC O'Neill, A Pertek, GG Westmeyer, M Drukker Nucleus size and DNA accessibility are linked to the regulation of paraspeckle formation in cellular differentiation BMC Biol., 2020-04-22;18(1):42. 2020-04-22 [PMID: 32321486] (Cell Culture, Human)
• M Asakawa, M Itoh, T Suganami, T Sakai, S Kanai, I Shirakawa, X Yuan, T Hatayama, S Shimada, Y Akiyama, K Fujiu, Y Inagaki, I Manabe, S Yamaoka, T Yamada, S Tanaka, Y Ogawa Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis Sci Rep, 2019-12-20;9(1):19601. 2019-12-20 [PMID: 31862949] (Bioassay, In Vivo, Human, Xenograft)
• S Bijland, G Thomson, M Euston, K Michail, K Thümmler, S Mücklisch, CL Crawford, SC Barnett, M McLaughlin, TJ Anderson, C Linington, ER Brown, ER Kalkman, JM Edgar An in vitro model for studying CNS white matter: functional properties and experimental approaches F1000Res, 2019-01-29;8(0):117. 2019-01-29 [PMID: 31069065] (Bioassay, Mouse)
• H Murata, T Tsuzuki, T Kido, M Kakita-Kob, N Kida, Y Hisamatsu, H Okada Progestin-induced heart and neural crest derivatives-expressed transcript 2 inhibits angiopoietin 2 via fibroblast growth factor 9 in human endometrial stromal cells Reprod Biol, 2019-03-06;0(0):. 2019-03-06 [PMID: 30852242] (Bioassay, Human)
• WKW Ho, L Freem, D Zhao, KJ Painter, TE Woolley, EA Gaffney, MJ McGrew, A Tzika, MC Milinkovit, P Schneider, A Drusko, F Matthäus, JD Glover, KL Wells, JA Johansson, MG Davey, HM Sang, M Clinton, DJ Headon Feather arrays are patterned by interacting signalling and cell density waves PLoS Biol., 2019-02-21;17(2):e3000132. 2019-02-21 [PMID: 30789897] (Bioassay, Chicken)
• H Wu, K Uchimura, EL Donnelly, Y Kirita, SA Morris, BD Humphreys Comparative Analysis and Refinement of Human PSC-Derived Kidney Organoid Differentiation with Single-Cell Transcriptomics Cell Stem Cell, 2018-11-15;0(0):. 2018-11-15 [PMID: 30449713] (Bioassay, Human)
• Bajaj P, Rodrigues A, Steppan C, Engle S, Mathialagan S, Schroeter T Human Pluripotent Stem Cell-Derived Kidney Model for Nephrotoxicity Studies. Drug Metab Dispos, 2018-08-31;46(11):1703-1711. 2018-08-31 [PMID: 30171163] (Bioassay, Human)
• CW van den Be, L Ritsma, MC Avramut, LE Wiersma, BM van den Be, DG Leuning, E Lievers, M Koning, JM Vanslambro, AJ Koster, SE Howden, M Takasato, MH Little, TJ Rabelink Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In�Vivo Stem Cell Reports, 2018-03-01;0(0):. 2018-03-01 [PMID: 29503086] (Bioassay, Human)
• LF Schütz, RE Hurst, NB Schreiber, LJ Spicer Transcriptome profiling of bovine ovarian theca cells treated with fibroblast growth factor 9 Domest. Anim. Endocrinol., 2018-01-04;63(0):48-58. 2018-01-04 [PMID: 29413902] (Cell Culture, Human)
• KE Tumelty, N Higginson-, X Fan, P Bajaj, KM Knowlton, M Shamashkin, AJ Coyle, W Lu, SP Berasi Identification of direct negative crosstalk between the SLIT2 and Bone Morphogenetic Protein-Gremlin signaling pathways J. Biol. Chem., 2018-01-09;0(0):. 2018-01-09 [PMID: 29317497] (Bioassay, Human)
• A Taguchi, R Nishinakam Higher-Order Kidney Organogenesis from Pluripotent Stem Cells Cell Stem Cell, 2017-11-09;0(0):. 2017-11-09 [PMID: 29129523] (Bioassay, Human)
• R Doi, T Tsuchiya, N Mitsutake, S Nishimura, M Matsuu-Mat, Y Nakazawa, T Ogi, S Akita, H Yukawa, Y Baba, N Yamasaki, K Matsumoto, T Miyazaki, R Kamohara, G Hatachi, H Sengyoku, H Watanabe, T Obata, LE Niklason, T Nagayasu Transplantation of bioengineered rat lungs recellularized with endothelial and adipose-derived stromal cells Sci Rep, 2017-08-16;7(1):8447. 2017-08-16 [PMID: 28814761] (Bioassay, Rat)
• JD Glover, KL Wells, F Matthäus, KJ Painter, W Ho, J Riddell, JA Johansson, MJ Ford, CAB Jahoda, V Klika, RL Mort, DJ Headon Hierarchical patterning modes orchestrate hair follicle morphogenesis PLoS Biol., 2017-07-11;15(7):e2002117. 2017-07-11 [PMID: 28700594] (Bioassay, Mouse)
• N Pode-Shakk, R Gershon, G Tam, D Omer, Y Gnatek, I Kanter, S Oriel, G Katz, O Harari-Ste, T Kalisky, B Dekel Evidence of In�Vitro Preservation of Human Nephrogenesis at the Single-Cell Level Stem Cell Reports, 2017-05-25;0(0):. 2017-05-25 [PMID: 28552604] (Bioassay, Human)
• E El Agha, V Kheirollah, A Moiseenko, W Seeger, S Bellusci Ex vivo analysis of the contribution of FGF10(+) cells to airway smooth muscle cell formation during early lung development Dev. Dyn., 2017-06-01;0(0):. 2017-06-01 [PMID: 28387977] (Bioassay, Mouse)
• Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells Nat Protoc, 2016-12-22;12(1):195-207. 2016-12-22 [PMID: 28005067] (Bioassay, Human)
• L J Spicer Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle Mol. Cell. Endocrinol., 2016-11-03;0(0):. 2016-11-03 [PMID: 27816766] (Bioassay, Bovine)
• G Tan, E Liang, K Liao, F Deng, W Zhang, Y Chen, J Xu, F Zhi NOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-?B subunit c-Rel in Paneth cell-like cells Oncotarget, 2016-09-27;7(39):63651-63660. 2016-09-27 [PMID: 27563808] (Bioassay, Human)
• Yin H, Frontini M, Arpino J, Nong Z, O'Neil C, Xu Y, Balint B, Ward A, Chakrabarti S, Ellis C, Gros R, Pickering J Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases. J Biol Chem, 2015-07-16;290(36):22127-42. 2015-07-16 [PMID: 26183774] (Bioassay, Mouse)
• Sun C, Fukui H, Hara K, Zhang X, Kitayama Y, Eda H, Tomita T, Oshima T, Kikuchi S, Watari J, Sasako M, Miwa H FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells. BMC Cancer, 2015-04-30;15(0):333. 2015-04-30 [PMID: 25925261] (Bioassay, Human)
• Meier F, Giesert F, Delic S, Faus-Kessler T, Matheus F, Simeone A, Holter S, Kuhn R, Weisenhorn D, Wurst W, Prakash N FGF/FGFR2 signaling regulates the generation and correct positioning of Bergmann glia cells in the developing mouse cerebellum. PLoS ONE, 2014-07-01;9(7):e101124. 2014-07-01 [PMID: 24983448] (Cell Culture, Mouse)
• Lam A, Freedman B, Morizane R, Lerou P, Valerius M, Bonventre J Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol, 2013-12-19;25(6):1211-25. 2013-12-19 [PMID: 24357672] (Bioassay, Human)
• Taguchi A, Kaku Y, Ohmori T, Sharmin S, Ogawa M, Sasaki H, Nishinakamura R Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell, 2013-12-12;14(1):53-67. 2013-12-12 [PMID: 24332837] (Bioassay, Mouse)
• Teishima J, Shoji K, Hayashi T Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence. Prostate Cancer Prostatic Dis., 2011-10-18;15(1):8-14. 2011-10-18 [PMID: 22006051] (Bioassay, Human)
• Frontini MJ, Nong Z, Gros R, Drangova M, O'Neil C, Rahman MN, Akawi O, Yin H, Ellis CG, Pickering JG Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat. Biotechnol., 2011-04-17;29(5):421-7. 2011-04-17 [PMID: 21499246] (In Vivo, Mouse)
• Tomlinson DC, Knowles MA Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. Am. J. Pathol., 2010-10-01;177(5):2379-86. 2010-10-01 [PMID: 20889570] (Bioassay, Human)
• Nakayama T, Mutsuga N, Tosato G FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood, 2006-10-31;109(4):1363-72. 2006-10-31 [PMID: 17077327] (Bioassay, Mouse)
• Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res., 2006-02-01;66(3):1354-62. 2006-02-01 [PMID: 16452189] (Bioassay, Human)
• Cinaroglu A, Ozmen Y, Ozdemir A, Ozcan F, Ergorul C, Cayirlioglu P, Hicks D, Bugra K Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina. J. Neurosci. Res., 2005-02-01;79(3):329-39. 2005-02-01 [PMID: 15614790] (Bioassay, Rat)
• Schmahl J, Kim Y, Colvin JS, Ornitz DM, Capel B Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development, 2004-06-30;131(15):3627-36. 2004-06-30 [PMID: 15229180] (Bioassay, Mouse)

Bioinformatics

• Gene Symbol: FGF9
• Uniprot:
  • P31371()